Hide metadata

dc.date.accessioned2018-03-09T14:09:18Z
dc.date.available2018-03-09T14:09:18Z
dc.date.created2017-10-27T18:33:14Z
dc.date.issued2017
dc.identifier.citationLossius, Peter Andreas Vold Tomescu-Baciu, Alina Holmøy, Trygve Vedeler, Christian A. Røsjø, Egil Rørvik Lorentzen, Åslaug Rudjord Casetta, Ilaria Vartdal, Frode . Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis. Annals of clinical and translational neurology. 2017, 4(10), 756-761
dc.identifier.urihttp://hdl.handle.net/10852/60789
dc.description.abstractImmunoglobulin gamma (IgG) heavy chain genes are associated with susceptibility to multiple sclerosis (MS) and IgG levels in the cerebrospinal fluid (CSF). However, how these variants are implicated in disease mechanisms remains unknown. Here, we show that proliferating plasmablasts expressing the G1m1 allotype of IgG1 are selectively enriched in CSF of G1m1/G1m3 heterozygous MS patients, whereas plasmablasts expressing either G1m1 or G1m3 are evenly distributed in blood. Moreover, there was a preferential intrathecal synthesis of oligoclonal IgG1 of the G1m1 allotype in heterozygous patients, whereas controls with Lyme neuroborreliosis displayed oligoclonal IgG1 of both allotypes. This points to a disease-specific mechanism involved in B-cell establishment within the central nervous system in MS.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleSelective intrathecal enrichment of G1m1-positive B cells in multiple sclerosisen_US
dc.typeJournal articleen_US
dc.creator.authorLossius, Peter Andreas Vold
dc.creator.authorTomescu-Baciu, Alina
dc.creator.authorHolmøy, Trygve
dc.creator.authorVedeler, Christian A.
dc.creator.authorRøsjø, Egil Rørvik
dc.creator.authorLorentzen, Åslaug Rudjord
dc.creator.authorCasetta, Ilaria
dc.creator.authorVartdal, Frode
cristin.unitcode185,53,18,12
cristin.unitnameAvdeling for immunologi og transfusjonsmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1508458
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Annals of clinical and translational neurology&rft.volume=4&rft.spage=756&rft.date=2017
dc.identifier.jtitleAnnals of clinical and translational neurology
dc.identifier.volume4
dc.identifier.issue10
dc.identifier.startpage756
dc.identifier.endpage761
dc.identifier.doihttp://dx.doi.org/10.1002/acn3.451
dc.identifier.urnURN:NBN:no-63434
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn2328-9503
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/60789/1/Selective%2Bintrathecal%2Benrichment%2Bof%2BG1m1-positive%2BB%2Bcells%2Bin.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International